- Home
- ALTS vs ASRT Comparison
ALTS vs ASRT Comparison
Compare ALTS & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- ASRT
- Stock Information
- Founded
- ALTS 1976
- ASRT 1995
- Country
- ALTS United States
- ASRT United States
- Employees
- ALTS N/A
- ASRT N/A
- Industry
- ALTS
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- ASRT Health Care
- Exchange
- ALTS NYSE
- ASRT Nasdaq
- Market Cap
- ALTS 159.4M
- ASRT 57.9M
- IPO Year
- ALTS N/A
- ASRT 1997
- Fundamental
- Price
- ALTS $7.88
- ASRT $0.69
- Analyst Decision
- ALTS
- ASRT Strong Buy
- Analyst Count
- ALTS 0
- ASRT 2
- Target Price
- ALTS N/A
- ASRT $3.25
- AVG Volume (30 Days)
- ALTS 298.1K
- ASRT 259.0K
- Earning Date
- ALTS 08-18-2025
- ASRT 08-06-2025
- Dividend Yield
- ALTS N/A
- ASRT N/A
- EPS Growth
- ALTS N/A
- ASRT N/A
- EPS
- ALTS N/A
- ASRT N/A
- Revenue
- ALTS $18,046,000.00
- ASRT $119,001,000.00
- Revenue This Year
- ALTS $185.91
- ASRT N/A
- Revenue Next Year
- ALTS $64.93
- ASRT $11.91
- P/E Ratio
- ALTS N/A
- ASRT N/A
- Revenue Growth
- ALTS N/A
- ASRT N/A
- 52 Week Low
- ALTS $1.29
- ASRT $0.51
- 52 Week High
- ALTS $10.95
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- ALTS 47.13
- ASRT 64.38
- Support Level
- ALTS $7.06
- ASRT $0.63
- Resistance Level
- ALTS $8.38
- ASRT $0.67
- Average True Range (ATR)
- ALTS 0.91
- ASRT 0.03
- MACD
- ALTS -0.17
- ASRT 0.01
- Stochastic Oscillator
- ALTS 33.51
- ASRT 86.37
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.